In April 2025, Pfizer organized a study is to learn about the effects, safety and how PF-06823859 is processed in adults with ...

Q1 2025 Earnings Call Transcript May 8, 2025 Royalty Pharma plc beats earnings expectations. Reported EPS is $1.06, ...

Biogen's litifilimab, which targets BDCA2 on plasmacytoid dendritic cells, has drawn particular attention for its monthly dosing, steroid-sparing potential, and novel mechanism of action. As one ...

Beginning with litifilimab, this is a potential first ... Ecopipam is a first-in-class potential therapy with a novel mechanism of action which we believe has a high probability of clinical ...

Biogen’s litifilimab, which targets BDCA2 on plasmacytoid dendritic cells, has drawn particular attention for its monthly dosing, steroid-sparing potential, and novel mechanism of action.

Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar's(TM) Ability to Inhibit DeUbiquitinating ...

and act via a previously unknown mechanism. In the newly published study, researchers led by Dr. Jennifer Herrmann and Prof. Rolf Müller uncovered the novel mode of action of chlorotonils.

This process is governed by a delicate mechanism called electroweak symmetry breaking, which was first proposed in 1964 but remains among the least understood phenomena of the Standard Model of ...

This accolade serves not just as a personal milestone but as a celebration of the collective action and unwavering commitment of advocates, changemakers and visionaries who stand together in the fight ...